Ligand validation:7VC1

JE6: ~{N}-[4-[(3~{S})-3-cyano-3-cyclopropyl-2-oxidanylidene-pyrrolidin-1-yl]-6-methyl-pyridin-2-yl]-2-phenyl-ethanamide

JE6 is a Ligand Of Interest in 7VC1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VC1_JE6_A_901	44%	70%	0.172	0.898	0.17	0.95	-	2	0	0	100%	0.77
7EVV_JE6_A_901	92%	69%	0.071	0.961	0.55	0.63	-	1	0	0	100%	1
7F9P_JE6_A_901	92%	83%	0.062	0.95	0.13	0.64	-	1	0	0	100%	0.94
7F9R_JE6_A_901	86%	81%	0.092	0.96	0.18	0.62	-	1	0	0	100%	0.96
7EVU_JE6_A_902	66%	74%	0.111	0.915	0.33	0.67	-	1	0	0	100%	1
8JE7_JE6_B_1802	96%	78%	0.058	0.967	0.19	0.7	-	1	1	0	100%	0.89
7X09_JE6_A_1902	83%	76%	0.102	0.962	0.22	0.71	-	2	0	0	100%	0.98
7F9B_JE6_B_1901	82%	82%	0.104	0.959	0.19	0.59	-	-	0	0	100%	0.99

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.